Matica Announces Intent to Acquire a Control Position in a Research & Development Company

February 8, 2018 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to announce the the Company signed a non-binding letter of intent (“LOI”) for Matica to purchase a controlling interest in a Quebec based health and personal care research and innovation technology company. We are pleased to have come to an agreement on terms and will quickly proceed to a definitive agreement (the “Agreement”).  

As Matica nears the completion of its cannabis growing facility in Dorval, management recognizes the acute need for alternative cannabis delivery systems, including pain relief topicals.  With this acquisition Matica can direct research to produce new topical products such as balms, creams and salves.  The target company is based just outside of Montreal and is a leader in sustainable, clean, health and personal care products.  Using proprietary mineral and plant based suspension technologies which can create unique alternative clean ingredients, Matica intends to develop revolutionary topical products within the cannabis space.

After successful due diligence and signing of the definitive agreement, Matica will invest $2,000,000 to acquire a 25 per cent interest.


For more information on Matica please visit the website at:

On behalf of the Board of Directors


/s/Boris Ziger

Boris Ziger, CEO & Chairman


The Company’s filings are available for review at and

For further information, please contact Boris Ziger, Chief Executive Officer, at:

Telephone: 416-304-9935




Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at

The CSE has not reviewed, approved or disapproved the content of this press release.